Daniel Nyqvist Group

Assistant professor

Daniel Nyqvist

Phone: 08-524 878 87
Organizational unit: Daniel Nyqvist Group
E-mail: daniel.nyqvist@ki.se

Daniel Nyqvist's profile page.

Research

The common goal of our research is to identify and characterize signaling pathways that play a critical role for vascular development and function in health and disease. We are interested in the mechanisms that regulate both vessel growth and function in normal and disease conditions, primarily cancer and diabetes.

Research Projects

Wnt/β-catenin signaling in vascular growth and function

The Wnt pathway controls numerous cellular mechanisms throughout development and adult life, and underlies a wide range of human pathologies. Wnts comprise a large family of secreted glycolipoproteins that signals via Frizzled and LRP receptors. In the canonical pathway, the binding of Wnt to its receptors blocks the phosphorylation and degradation of β-catenin, and enables β-catenin to ac Active beta-catenin signaling (green nuclei) in the retinal vasculature (red) at post-natal day 5 of transgenic BAT-gal mice.cumulate and translocate to the nucleus to activate gene transcription. In addition to its role as a transcription factor, β-catenin function as a component of the adherens junctions and thus provides a link between cell adhesion and signaling. Genetic disorders have revealed a critical role for canonical Wnt/β-catenin signaling for the development of the retinal vasculature in humans, while extensive research has showed that Wnt/β-catenin signaling is vital for CNS angiogenesis and blood-brain barrier (BBB) formation.

Our research is focused on elucidating the role of endothelial Wnt/β-catenin signaling in vascular growth and. We have previously found that endothelial Wnt/β-catenin is an important player during embryonic vascular development by modulating vessel remodeling and up-regulating Dll4/Notch signaling. We are now investigating the role of endothelial Wnt/β-catenin signaling during post-natal vascular developmental and tumor angiogenesis.

VEGF-B signaling in pancreatic β-cell lipid uptake and physiology

The vascular endothelial growth factor (VEGF)-B was recently discovered to control the transport of fatty acids over the endothelium. Paracrine VEGF-B signaling regulates the expression of fatty acid transporters (FATPs) on endothelial cells and thereby trans-endothelial lipid transport. VEGF-B deficient mice have reduced expression of endothelial FATPs and reduced peripheral lipid uptake (Hagberg et al., Nature 2010). We have recently found that blocking VEGF-B signaling in models of type 2 diabetes dramatically reduces lipid uptake to peripheral tissues, improves insulin resistance and glucose tolerance, and protects against development of type 2 diabetes. Interestingly, also pancreatic morphology and triglyceride content were significantly improved after targeting the VEGF-B pathway.

Extensive research has identified increased and dysregulated lipid handling as an early hallmark of β-cell dysfunction and failure during development of type 2 diabetes. Our goal with this project is to elucidate the role of paracrine VEGF-B signaling for pancreatic islets and β-cells lipid handling in normal and type 2 diabetic conditions.

Dynamic imaging of angiogenesis and tumor angiogenesis

Vessel growth and function (e.g. transport and permeabilization) are highly dynamic processes. To provide a better understanding of these processes and their underlying mechanisms we are currently developing methods for live cell and in vivo confocal imaging. We have previously established a novel model for in vivo imaging of pancreatic islets transplanted to the anterior chamber of the eye (AC). This model facilitates noninvasive and repetitive high-resolution imaging of tissue implanted in the AC using the cornea as a natural body window. We are currently adapting this model to facilitate high-resolution imaging of angiogenesis and tumor angiogenesis in 4 dimensions (4D). To aid the visualization of different cell types and signaling process we take advantages of a variety of fluorescent reporters models.

 

Current research in the laboratory is supported by:

  • The Swedish Research Council
  • Swedish Society for Medical Research (SSMF)
  • The Cancer Society (Cancerfonden)
  • The Diabetes association (Diabetesfonden)
  • Diabetes Wellness Foundation
  • Karolinska Institutet
  • Åke Wibergs Stiftelse
  • O.E och Edla Johanssons Vetenskapliga Stiftelse
  • Magnus Bergvalls Stiftelse
  • Stiftelsen Sigurd och Elsa Goljes Minne
  • Eva och Oscar Ahréns Stiftelse

Research Group

Dominic AlibhaiPostdoc
Mirela BalanAssociated
Agnieszka MartowiczPostdoc
Chenfei NingResearch assistant on study grant
Daniel NyqvistAssistant professor
Joanna Wisniewska-KrukAssociated

Agnieszka Martowicz Post-doc

Open Positions

Applications for a post-doc position related to the projects “ Wnt/β-catenin signaling in vascular growth and function” and “Dynamic imaging of angiogenesis and tumor angiogenesis” are currently welcome.

Please send cover letter and CV to Daniel Nyqvist.